Acute and Chronic Effects of Cancer Drugs on the Cardiovascular System.
Anthracycline
CTRCD
Cardio-oncology
Cardiotoxicity
GVHD
Hematopoietic stem cell transplantation
Trastuzumab
Journal
Heart failure clinics
ISSN: 1551-7136
Titre abrégé: Heart Fail Clin
Pays: United States
ID NLM: 101231934
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
entrez:
8
3
2020
pubmed:
8
3
2020
medline:
12
9
2020
Statut:
ppublish
Résumé
Several cancer treatments cause cardiotoxicity that can lead to heart failure, coronary artery disease, arrhythmia, and pericardial disease. In this review, representative cases of heart failure following cardiotoxicity caused by trastuzumab, anthracycline, and hematopoietic stem cell transplantation are described with case notes. Additionally, other important points regarding cardiotoxicity related to heart failure are reported. During and after potentially cardiotoxic therapy, periodic cardiac examinations are recommended to detect any cardiovascular disorders; these are ameliorated if appropriately diagnosed at an earlier stage. It is important for cardiologists and oncologists to understand the pathophysiology of representative cardiovascular disease cases following cancer treatment.
Identifiants
pubmed: 32143767
pii: S1551-7136(19)30114-X
doi: 10.1016/j.hfc.2019.11.002
pii:
doi:
Substances chimiques
Anthracyclines
0
Antineoplastic Agents
0
Trastuzumab
P188ANX8CK
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
231-241Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.